Page last updated: 2024-08-21

cyclopentane and Lymphoma, Large B-Cell, Diffuse

cyclopentane has been researched along with Lymphoma, Large B-Cell, Diffuse in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assumpção, ALFV; Lu, Z; Marlowe, KW; Pan, X; Shaffer, KS1
Berger, A; Danes, C; Danilov, AV; Danilova, OV; Godbersen, JC; Paiva, C; Rowland, T1
Adams-Duffy, J; Berger, AJ; Bolen, JB; Dang, L; Dick, LR; Garnsey, JJ; Koenig, E; Langston, SP; Manfredi, M; Milhollen, MA; Narayanan, U; Rolfe, M; Smith, PG; Soucy, TA; Staudt, LM; Thomas, MP; Traore, T; Yu, J; Zhang, J1
BRUNORI, M; CAPUTO, A; GIULIANO, R1
Khokhar, AR; Siddik, ZH; Thai, G; Yoshida, M; Zhang, YP1
Baumgartner, RA; Beaven, MA; Deramo, VA1

Other Studies

6 other study(ies) available for cyclopentane and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Targeting NEDD8-activating enzyme is a new approach to treat canine diffuse large B-cell lymphoma.
    Veterinary and comparative oncology, 2018, Volume: 16, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred NOD; NEDD8 Protein; Neoplasm Transplantation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Ubiquitin-Activating Enzymes

2018
Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis.
    Oncotarget, 2017, Mar-28, Volume: 8, Issue:13

    Topics: Antineoplastic Agents; Apoptosis; B-Lymphocytes; Cyclopentanes; Enzyme Inhibitors; Humans; Immunoblotting; Immunoprecipitation; Lymphoma, Large B-Cell, Diffuse; NEDD8 Protein; Pyrimidines; Receptors, Death Domain; Ubiquitins

2017
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.
    Blood, 2010, Sep-02, Volume: 116, Issue:9

    Topics: Animals; Apoptosis; B-Lymphocytes; Blotting, Western; Cell Cycle; Cell Proliferation; Cyclopentanes; DNA Replication; Female; Flow Cytometry; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred NOD; Mice, SCID; NEDD8 Protein; NF-kappa B; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ubiquitins; Xenograft Model Antitumor Assays

2010
STUDIES ON THE ACTION OF NEW SARCOMYCIN DERIVATIVES.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Animals; Carboxylic Acids; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Cyclopentanes; Fibrosarcoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Rats; Research; Sarcoma; Sarcoma, Experimental

1964
Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Anti-cancer drug design, 1994, Volume: 9, Issue:6

    Topics: Amines; Animals; Antineoplastic Agents; Cisplatin; Cyclohexanes; Cyclopentanes; Dose-Response Relationship, Drug; Drug Resistance; Female; Leukemia L1210; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organoplatinum Compounds; Platinum Compounds

1994
Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Nov-01, Volume: 157, Issue:9

    Topics: Animals; Brefeldin A; Cyclopentanes; Dexamethasone; Enzyme Inhibitors; Gene Expression Regulation; Golgi Apparatus; Humans; Indoles; Leukemia, Basophilic, Acute; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Macrophage Activation; Macrophages; Maleimides; Mast Cells; Protein Kinase C; Rats; Signal Transduction; T-Lymphocytes; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1996